Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
Understanding How the Microbiome Affects Radiation Injury for Countermeasure Development CBRNE October 11, 2021 …
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine Medical Countermeasures October 4, 2021 …
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA Industry News October 3, 2021 …
DTRA Works to Create Freeze-Dried Portable Biomanufacturing for Nimble Response to Emerging Biothreats Medical Countermeasures September 30, 2021 …
By Targeting Key Part of Spike Protein, This Antibody Protects Against Broad Range of COVID Variants Medical Countermeasures September 29, 2021 …
Made-in-Melbourne mAbs Could Bolster Australia’s COVID Response Medical Countermeasures September 29, 2021 …
Soligenix COVID-19 Vaccine Demonstrates Efficacy in Non-Human Primates Industry News September 28, 2021 …
New J&J Data Shows Second COVID Shot Boosts Antibodies and Protection – But Single Dose Still Strong Against Delta Variant Medical Countermeasures September 25, 2021 …
New Treatments for COVID-19 May Stave Off the Worst Effects of the Virus Medical Countermeasures September 24, 2021 …
Navrogen Enters CRADA with USAMRIID to Test Small Molecule NK Cell Activators Against SARS-COV-2 Infection Industry News September 13, 2021 …
Messenger RNA: How it Works in Nature and in Making Vaccines Medical Countermeasures September 6, 2021 …
Humanetics’ Radiation Medical Countermeasure Receives FDA Fast Track Designation CBRNE August 24, 2021 …
What Does Full Approval of a Vaccine Do If It’s Already Authorized for Emergency Use? Medical Countermeasures August 12, 2021 …
Phase 1 Trial Begins for Oxford University’s ChAdOx1 Plague Vaccine Medical Countermeasures July 26, 2021 …
NIAID to Create New Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Contracts + Grants July 13, 2021 …
